Neuroone Medical Technologies (NMTC) Shares Outstanding (Weighted Average) (2010 - 2026)

Neuroone Medical Technologies has disclosed Shares Outstanding (Weighted Average) across 17 years of filings, most recently posting $8.5 million for Q1 2026.

• Quarterly Shares Outstanding (Weighted Average) rose 63.64% year-over-year to $8.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.5 million (up 63.64% YoY) and the FY2025 annual result came in at $40.2 million, up 50.03% from the prior year.
• Shares Outstanding (Weighted Average) declined to $8.5 million in Q1 2026, from $50.3 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $50.3 million in Q4 2025 and bottomed at $5.2 million in Q1 2025.
• The 5-year median for Shares Outstanding (Weighted Average) is $18.1 million (2023), against an average of $23.7 million.
• The widest YoY moves for Shares Outstanding (Weighted Average): up 88.78% in 2025, down 79.99% in 2025.
• Neuroone Medical Technologies' Shares Outstanding (Weighted Average) stood at $16.2 million in 2022, then surged by 47.84% to $24.0 million in 2023, then rose by 28.51% to $30.8 million in 2024, then jumped by 63.21% to $50.3 million in 2025, then tumbled by 83.14% to $8.5 million in 2026.
• According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $8.5 million, $50.3 million, and $40.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.